Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back

The Drug-Induced Respiratory Disease Website and App

Nonsteroidal anti-inflammatory drugs (NSAIDs)

Risks depends on COX-selectivity. Review and guidelines at PMID 21631520. Studies on selective rechallenge at PMID 21981353 and 23278883

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I - Interstitial/parenchymal lung disease

XLI - Pulmonary edema - Acute lung injury - ARDS

XLIII - Airway involvement

XLIV - Central-large-upper airway (incl. pharyngeal-nasal) involvement

XLV - Pleural and/or pericardial involvement

XLVII - Mediastinal involvement

XLVIII - Neuromuscular / CNS involvement - Disordered breathing (during sleep)

XLIX - Systemic/Distant conditions, syndromes and reactions

L - Miscellaneous

LIII - Hemoglobinopathies - Abnormal hemoglobin states (acquired)